These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25773279)

  • 1. Monogenic diabetes: the treatment options.
    Owen KR
    Diabet Med; 2015 Apr; 32(4):429-30. PubMed ID: 25773279
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful switch from insulin to oral sulfonylurea therapy in HNF1A-MODY Tunisian patient with the P291fsinsC mutation.
    Khelifa SB; Dendana A; Barboura I; Khochtali I; Chahed H; Ferchichi S; Miled A
    Diabetes Res Clin Pract; 2016 May; 115():133-6. PubMed ID: 26822262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of young patients with HNF1A mutations (HNF1A-MODY).
    Raile K; Schober E; Konrad K; Thon A; Grulich-Henn J; Meissner T; Wölfle J; Scheuing N; Holl RW;
    Diabet Med; 2015 Apr; 32(4):526-30. PubMed ID: 25483937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A; Minuchin O
    Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J
    Nihon Rinsho; 1997 Nov; 55 Suppl():255-60. PubMed ID: 9434477
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.
    Jesić MD; Sajić S; Jesić MM; Maringa M; Micić D; Necić S
    Diabetes Res Clin Pract; 2008 Jul; 81(1):e1-3. PubMed ID: 18433912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sulfonylurea-pioglitazone combination agent].
    Hashiramoto M; Kaku K
    Nihon Rinsho; 2012 May; 70 Suppl 3():633-41. PubMed ID: 22768590
    [No Abstract]   [Full Text] [Related]  

  • 8. Could FFAR1 assist insulin secretion in type 2 diabetes?
    Bailey CJ
    Lancet; 2012 Apr; 379(9824):1370-1. PubMed ID: 22374407
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of diabetes mellitus].
    Kaneko T
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):406-9. PubMed ID: 8315336
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():442-6. PubMed ID: 12387031
    [No Abstract]   [Full Text] [Related]  

  • 11. Pareto's law and sulfonylureas.
    Peiris AN; Micklewright M; Gangadharan V
    South Med J; 2007 Nov; 100(11):1072-3. PubMed ID: 17984734
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract]   [Full Text] [Related]  

  • 13. SGLT2 inhibitors for diabetes: turning symptoms into therapy.
    Diamant M; Morsink LM
    Lancet; 2013 Sep; 382(9896):917-8. PubMed ID: 23850056
    [No Abstract]   [Full Text] [Related]  

  • 14. The UK Prospective Diabetes Study.
    Evans M
    Lancet; 1998 Dec; 352(9144):1932-3; author reply 1934. PubMed ID: 9863807
    [No Abstract]   [Full Text] [Related]  

  • 15. The UK Prospective Diabetes Study.
    Bailey CJ; Grant PJ
    Lancet; 1998 Dec; 352(9144):1932; author reply 1934. PubMed ID: 9863806
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy for NIDDM: has its time arrived?
    Menke J
    S D J Med; 1995 Aug; 48(8):246-7. PubMed ID: 7569874
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].
    Furukawa H; Ishida H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():357-61. PubMed ID: 12387018
    [No Abstract]   [Full Text] [Related]  

  • 18. Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
    Roselli A; Hayes JD; Seidner R; Marchione V; Snyder CM; Mayes K; Stiernberg CM; Milgram L
    Manag Care; 2001 Feb; 10(2 Suppl):17-21. PubMed ID: 11729404
    [No Abstract]   [Full Text] [Related]  

  • 19. Monogenic Diabetes: Not Your "Typical" Diabetes.
    Wiley F
    Diabetes Self Manag; 2016; 33(4):36-7. PubMed ID: 27491106
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.